Emerging pharmacologic treatment options for fragile X syndrome

por Schaefer, Tori L, Davenport, Matthew H, Erickson, Craig A
Publicado 2015

Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency

por Skelton, Matthew R., Schaefer, Tori L., Graham, Devon L., deGrauw, Ton J., Clark, Joseph F., Williams, Michael T., Vorhees, Charles V.
Publicado 2011

Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in rats

por Herring, Nicole R, Schaefer, Tori L, Tang, Peter H, Skelton, Matthew R, Lucot, James P, Gudelsky, Gary A, Vorhees, Charles V, Williams, Michael T
Publicado 2008

In Utero and Lactational Exposure to PCBs in Mice: Adult Offspring Show Altered Learning and Memory Depending on Cyp1a2 and Ahr Genotypes

por Curran, Christine P., Nebert, Daniel W., Genter, Mary Beth, Patel, Krishna V., Schaefer, Tori L., Skelton, Matthew R., Williams, Michael T., Vorhees, Charles V.
Publicado 2011

Effects of developmental manganese, stress, and the combination of both on monoamines, growth, and corticosterone

por Vorhees, Charles V., Graham, Devon L., Amos-Kroohs, Robyn M., Braun, Amanda A., Grace, Curtis E., Schaefer, Tori L., Skelton, Matthew R., Erikson, Keith M., Aschner, Michael, Williams, Michael T.
Publicado 2014

Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety

por Schaefer, Tori L., Davenport, Matthew H., Grainger, Lindsay M., Robinson, Chandler K., Earnheart, Anthony T., Stegman, Melinda S., Lang, Anna L., Ashworth, Amy A., Molinaro, Gemma, Huber, Kimberly M., Erickson, Craig A.
Publicado 2017

d-Cycloserine enhances durability of social skills training in autism spectrum disorder

por Wink, Logan K., Minshawi, Noha F., Shaffer, Rebecca C., Plawecki, Martin H., Posey, David J., Horn, Paul S., Adams, Ryan, Pedapati, Ernest V., Schaefer, Tori L., McDougle, Christopher J., Swiezy, Naomi B., Erickson, Craig A.
Publicado 2017

Fragile X targeted pharmacotherapy: lessons learned and future directions

por Erickson, Craig A., Davenport, Matthew H., Schaefer, Tori L., Wink, Logan K., Pedapati, Ernest V., Sweeney, John A., Fitzpatrick, Sarah E., Brown, W. Ted, Budimirovic, Dejan, Hagerman, Randi J., Hessl, David, Kaufmann, Walter E., Berry-Kravis, Elizabeth
Publicado 2017

GABA(A) Alpha 2,3 Modulation Improves Select Phenotypes in a Mouse Model of Fragile X Syndrome

por Schaefer, Tori L., Ashworth, Amy A., Tiwari, Durgesh, Tomasek, Madison P., Parkins, Emma V., White, Angela R., Snider, Andrew, Davenport, Matthew H., Grainger, Lindsay M., Becker, Robert A., Robinson, Chandler K., Mukherjee, Rishav, Williams, Michael T., Gibson, Jay R., Huber, Kimberly M., Gross, Christina, Erickson, Craig A.
Publicado 2021